Side effects of postoperative radiotherapy for nasopharyngeal carcinoma

Update Date: Source: Network

summary

I've had chronic rhinitis for many years. In recent years, I feel it's difficult to breathe. When I go to bed at night, I can't breathe. I often have insomnia. When I catch a cold, my head aches. I have lymph nodes in my neck and it's very swollen. I went to the hospital for a systematic examination. It's the early stage of nasopharyngeal carcinoma. Let's talk about the side effects of postoperative radiotherapy for nasopharyngeal carcinoma.

Side effects of postoperative radiotherapy for nasopharyngeal carcinoma

First, NPC metastases to the lung. In clinic, it is suggested that distant metastasis of cancer cells is the advanced stage of nasopharyngeal carcinoma. This stage is very difficult to cure, mainly radiotherapy combined with chemotherapy, immunotherapy! And pain relief and other symptomatic support treatment, improve the quality of life of patients.

Second, the first symptoms of NPC are mainly local invasion, such as headache caused by skull base invasion, corresponding symptoms caused by cranial nerve invasion, such as facial anesthesia, hearing loss, hoarseness, etc., nasal obstruction caused by nostril invasion, aspiration blood runny nose and intermittent epistaxis.

Third: the early and mid-term metastasis of nasopharyngeal carcinoma is via lymph node, the most common is to metastasize to submandibular and cervical lymph nodes, with cervical mass, and the late stage can metastasize to lung, liver, bone and joint through blood.

matters needing attention

It's not just about the respiratory system, it's about the disease as a whole. In fact, it occurs on the basis of deficiency of vital qi and low immune function, so the treatment is the whole treatment of strengthening vital energy, regulating immunity and anti-tumor. If it is transferred to the lung, it can also be transferred to other parts, so we should pay close attention to the treatment. The basis of pathogenicity cannot be determined.